Interleukin-12-stimulated natural killer cells can activate human macrophages to inhibit growth of Mycobacterium avium

• Published in: Infection and Immunity Vol. 63; no. 10; pp. 4099 - 4104
• Main Authors: BERMUDEZ, L. E, WU, M, YOUNG, L. S
• Format: Journal Article
• Language: English
• Published: Washington, DC American Society for Microbiology 01.10.1995
• Subjects: Analysis of the immune response. Humoral and cellular immunity; Animals; Bacteriology; Biological and medical sciences; Fundamental and applied biological sciences. Psychology; Fundamental immunology; Humans; Immunobiology; Interleukin-1 - pharmacology; Interleukin-10 - pharmacology; Interleukin-12 - pharmacology; Interleukin-2 - pharmacology; Killer Cells, Natural - immunology; Lymphokines, interleukins ( function, expression); Macrophage Activation - drug effects; Mice; Microbiology; Mycobacterium avium; Mycobacterium avium - immunology; Pathogenicity, virulence, toxins, bacteriocins, pyrogens, host-bacteria relations, miscellaneous strains; Recombinant Proteins - pharmacology; Regulatory factors and their cellular receptors; Transforming Growth Factor beta - pharmacology; Tumor Necrosis Factor-alpha - pharmacology; Cytokine; Mycobacterium avium; Host agent relation; Interleukin 12; Activation; Cellular immunity; In vitro; Natural killer cell; Mycobacteriales; Mycobacteriaceae; Bacteria; Actinomycetes; Infected cell; Macrophage

Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue IAI About IAI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissio...